Zephyrnet Logo

Tag: Ophthalmology

CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia

HONG KONG, China and WILMINGTON, Del., Apr 1, 2024 - (ACN Newswire) - China Medical System Holdings Limited (“CMS” or the “Group”) and Incyte (Nasdaq:INCY)...

Top News

About Those “AI Can Diagnose Autism!” Claims

Is it true that AI can diagnose autism? Short answer: No. Slightly longer and probably more accurate answer: Not yet. There’s been some buzz lately about articles...

Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD | BioSpace

Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD Study confirms subretinal prothesis feasible and well-tolerated with no reduction of natural...

InMode Expects Third Quarter 2023 Revenue Between $122.8M-$123.0M, Lowering Full-Year 2023 Revenue Guidance to $500M-$510M vs. Original Estimates of $530M-$540M | BioSpace

Conference call to be held on Thursday, Nov. 2, 2023, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Oct. 12, 2023 /PRNewswire/ -- InMode Ltd....

Ophthalmology Disorders and current developments of novel treatments under clinical trials

ProRelix Research is the best clinical research organization (CRO) with global service capability supporting Phase 1, 2, 3, & 4 clinical trials for Pharma,...

A DEA Judge Tried to Reschedule Cannabis 35 Years Ago

WASHINGTON – In 1988, a federal judge brashly ruled against the Reagan administration’s drug policy and declared cannabis fit for medical use. The controversial...

Why Including Patients in FDA Engagement Will Benefit Your Trial

August 23, 2023 Patients are the backbone of clinical trials, playing an essential role in the drug development process. However, patients...

Effect of adipose tissue-derived stem cells therapy on clinical response in patients with primary Sjogren’s syndrome – Scientific Reports

Ethical statementThis trial was conducted in full accordance with the 2010 CONSORT guidelines of the World Medical Association Declaration of Helsinki. The study protocol...

Iveric drug approved for type of vision loss as rival’s safety draws scrutiny

The Food and Drug Administration on Friday approved a second medicine for a common type of vision loss, clearing a drug developed by biotechnology...

Latest Intelligence

spot_img
spot_img